Annexon's top three insider shareholders as of March 23, 2026 are Muneer A Satter (Director, 9.73Mn shares), Capital Life Sciences Investors, Llc Bain (TenPercentOwner, 5.70Mn shares), Douglas Love (President And Ceo, 351.55K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Muneer A Satter | 0 | 9,728,637 | 21 Nov, 2025 | |
| Capital Life Sciences Investors, Llc Bain | 0 | 5,701,926 | 30 May, 2023 | |
| Douglas Love | President And Ceo | 351,554 | 0 | 18 Feb, 2025 |
| Michael Overdorf | Evp Chief Business Officer | 182,625 | 0 | 04 Mar, 2026 |
| Jennifer Lew | Evp Chief Financial Officer | 170,700 | 0 | 04 Mar, 2026 |
| Ted Yednock | Evp Chief Innovation Officer | 154,161 | 0 | 04 Mar, 2026 |
| Jamie Dananberg | Chief Medical Officer | 123,582 | 0 | 04 Mar, 2026 |
| William H. Carson | 62,405 | 0 | 12 Mar, 2026 | |
| Jung Choi | 0 | 33,000 | 03 Dec, 2025 | |
| Larry Mattheakis | Evp Chief Scientific Officer | 17,188 | 0 | 13 Jul, 2022 |
| Sanjay Keswani | Evp Chief Medical Officer | 12,500 | 0 | 15 Feb, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Mar, 2026 | William H. Carson | Common Stock | A | 8,000 | $5.67 | 62,405 | D | P |
| 02 Mar, 2026 | Ted Yednock | Common Stock | D | 5,566 | $5.42 | 154,161 | D | S |
| 02 Mar, 2026 | Jamie Dananberg | Common Stock | D | 5,820 | $5.43 | 123,582 | D | S |
| 02 Mar, 2026 | Jennifer Lew | Common Stock | D | 5,565 | $5.42 | 170,700 | D | S |
| 02 Mar, 2026 | Michael Overdorf | Common Stock | D | 4,339 | $5.42 | 182,625 | D | S |
| 19 Feb, 2026 | Ted Yednock | Common Stock | A | 62,500 | $0.00 | 159,727 | D | A |
| 19 Feb, 2026 | Jennifer Lew | Common Stock | A | 62,500 | $0.00 | 176,265 | D | A |
| 19 Feb, 2026 | Douglas Love | Stock Option (Right to Buy) | A | 1,250,000 | $0.00 | 1,250,000 | D | A |
| 19 Feb, 2026 | Michael Overdorf | Common Stock | A | 62,500 | $0.00 | 186,964 | D | A |
| 19 Feb, 2026 | Jamie Dananberg | Common Stock | A | 56,250 | $0.00 | 129,402 | D | A |
| 19 Feb, 2026 | Ted Yednock | Stock Option (Right to Buy) | A | 250,000 | $0.00 | 250,000 | D | A |
| 19 Feb, 2026 | Michael Overdorf | Stock Option (Right to Buy) | A | 250,000 | $0.00 | 250,000 | D | A |
| 19 Feb, 2026 | Jamie Dananberg | Stock Option (Right to Buy) | A | 225,000 | $0.00 | 225,000 | D | A |
| 19 Feb, 2026 | Jennifer Lew | Stock Option (Right to Buy) | A | 250,000 | $0.00 | 250,000 | D | A |
| 18 Feb, 2026 | Jamie Dananberg | Common Stock | D | 5,290 | $5.10 | 73,152 | D | S |
| 18 Feb, 2026 | Ted Yednock | Common Stock | D | 7,857 | $5.11 | 97,227 | D | S |
| 18 Feb, 2026 | Jennifer Lew | Common Stock | D | 7,851 | $5.11 | 113,765 | D | S |
| 18 Feb, 2026 | Michael Overdorf | Common Stock | D | 6,225 | $5.10 | 124,464 | D | S |
| 30 Dec, 2025 | William H. Carson | Common Stock | A | 4,115 | $5.02 | 54,405 | D | P |
| 01 Dec, 2025 | Jung Choi | Common Stock | A | 33,000 | $4.19 | 33,000 | I | P |